“My Monday is green…” Colored, silicon-coated lancets for simple smooth testing

Colored MICROLET® lancets from Bayer Diabetes Care remind people with diabetes of when it’s time to change

Leverkusen – Sterile, undamaged lancets are essential for smooth blood sampling. The reality is however very different: on average, these disposable lancets are used eight times before being replaced(1). Reusing the previously smooth needles can cause them to become deformed and blunt and can lead to microscopic barbs being formed. This makes them unnecessarily painful to use and delays healing of the puncture wound. In addition, contamination with almost invisible tissue and blood residue can cause infections at the injection site if the needle is reused.

Bayer Diabetes Care’s new colored MICROLET® lancets remind users to change the lancet each time they test: a different sampling color can be chosen for each measurement or day, for example “My Monday is green”. The silicon coating, another new feature on the lancets, makes lancing even more gentle and is particularly gentle on delicate fingertips. Colored MICROLET® lancets fit many conventional lancing devices. The MICROLET® 2 lancing device has also been further improved and its new ergonomic shape now fits in the user’s hand even better. The lancet ejection feature makes it quick and easy to eject a lancet without touching the needle.

Bayer HealthCare, Diabetes Care
Bayer HealthCare, Diabetes Care supports customers in 100 countries and stands in a long tradition of leading the way in diabetes care product innovation since the introduction of CLINITEST reagent tablets in 1941. The face of diabetes care was changed in 1969 when the first portable blood glucose meter and test strips were introduced. Bayer HealthCare further innovated diabetes management by being the first company to introduce a suite of blood glucose monitors with No Coding™ technology. The BREEZE®2 and CONTOUR® blood glucose monitoring systems offer people with diabetes an unparalleled choice in diabetes management systems.

In July 2006, Bayer HealthCare Diabetes Care acquired Metrika Inc., maker and manufacturer of A1CNow+, a meter-based diabetes monitoring system for measurement of HbA1c (glycated hemoglobin) an important indicator of long term blood sugar control. Bayer HealthCare Diabetes Care global headquarters is located in Tarrytown, New York, in the United States and operates as part of Bayer HealthCare LLC, a member of the worldwide Bayer HealthCare group. The Headquarters for the region Europe-MERA is located in Basel as part of Bayer Consumer Care AG, in Basel.

Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma. Bayer HealthCare’s aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.

We are only one click away – our press service online: www.viva.vita.bayerhealthcare.com

(1) (Source: Blutzuckerselbstmanagement Report Deutschland 2006)

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.